Related Experiment Video
Updated: Aug 14, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications
1Department of Dermatology and Allergy, Biederstein, Technical University of Munich, Germany.
Abstract:
Skin colonization with Staphylococcus aureus is a characteristic feature of atopic dermatitis with more than 90% of patients being colonized. Extracellular matrix proteins are important for the adherence of S. aureus to human keratinocytes. The bacterium interferes in the inflammatory process of atopic dermatitis in various ways, among which the ability to release superantigens in a high percentage of clinical isolates is of great importance. As the colonization correlates significantly with the severity of eczema, anti-staphylococcal treatment measurements are widely used. In cases of atopic dermatitis exacerbation with wide-spread weeping lesions, a systemic antibiotic treatment is warranted, with erythromycin no longer being recommended due to an increased resistance rate. In localized superinfected lesions the topical application of an antibiotic-glucocorticoid preparation may offer advantages to the mere steroid application. Based on efficacy and resistance data, fusidic acid is the antibiotic of choice. There is evidence that phototherapy in atopic dermatitis may be even more effective when combined with anti-staphylococcal measurements. In the future new therapeutical options may be available.
Insights
Staphylococcus aureus colonization is common in atopic dermatitis and linked to eczema severity. Anti-staphylococcal treatments, like fusidic acid, are crucial for managing this skin condition.
Area of Science:
- Dermatology
- Microbiology
- Immunology
Background:
- Atopic dermatitis (AD) is characterized by Staphylococcus aureus skin colonization in over 90% of patients.
- Extracellular matrix proteins facilitate S. aureus adherence to keratinocytes, impacting AD.
- S. aureus contributes to AD inflammation via mechanisms including superantigen release.
Purpose of the Study:
- To review the role of Staphylococcus aureus in atopic dermatitis.
- To discuss current and future therapeutic strategies targeting S. aureus in AD.
Main Methods:
- Literature review of studies on S. aureus and atopic dermatitis.
- Analysis of treatment guidelines and resistance patterns.
- Evaluation of therapeutic options including antibiotics and phototherapy.
Main Results:
- S. aureus colonization significantly correlates with AD severity.
- Erythromycin resistance is increasing, making it less recommended.
- Fusidic acid is recommended for topical treatment of superinfected lesions.
- Combination therapy with phototherapy and anti-staphylococcal measures may enhance efficacy.
Conclusions:
- Anti-staphylococcal treatments are essential for managing atopic dermatitis.
- Fusidic acid is a preferred topical antibiotic for AD.
- Future therapeutic options for S. aureus in AD are under development.
More Related Videos
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
The Skin Microbiota
Staphylococcal Skin Infections
Acne Infection
Clinical Significance of Antibiotic Resistance